Taiwan FDA registration a8c8a1c731b70c5322e4a7919e9fbf64

Constant pancreatic poly/assay reagent

TW: 常盈胰多/檢驗試劑
Taiwan flagTaiwan·Risk Class 2·IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH·Registered Feb 03, 2006 – Feb 03, 2011Cancelled
Registration details
Analysis ID
a8c8a1c731b70c5322e4a7919e9fbf64
Customs Code
DHAS0601595903
Company information
Manufacturer Country
Germany
Authorized Representative
WOLCH ENTERPRISES INC.
Product details
Intended Use
Radioimmunoassay was used to quantify the pancreatic presence in serum.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Import Information
Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
Registration Date
Feb 03, 2006
Expiry Date
Feb 03, 2011
Cancellation Date
Jul 26, 2011
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for Constant pancreatic poly/assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a8c8a1c731b70c5322e4a7919e9fbf64 and manufactured by IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices